Pure Appl. Chem., 2003, Vol. 75, No. 11-12, pp. 2605-2607
http://dx.doi.org/10.1351/pac200375112605
Endocrine disruption and the USFDA's Center for Drug Evaluation and Research
Individual author index pages
Other PAC articles by these authors
Risk management options for endocrine disruptors in national and international programs